Applications of PET/MRI in prostate cancer

Abstract

The advantages of both PET and MRI are combined with PET/MRI to provide near-perfect picture co-registration and simultaneous image capture. Prostate cancer and other pelvic oncologic lesions are increasingly being staged and restaged using magnetic resonance imaging (MRI). Long regarded as the cornerstone of oncologic imaging, fluorine 18-fluorodeoxyglucose PET/CT is now being studied and used in clinical practice more often due to the emergence of several tailored radiotracers. Therefore, PET/MRI performed concurrently offers a number of advantages over PET/CT and MR image collections, including the ability to obtain complementary imaging data. An overview of PET/MRI is given by the author, along with a discussion of the key distinctions between PET/MRI and PET/CT, case studies, and treatment guidelines for patients with common prostate cancers.